Kazuhiro Chiba
Corporate Officer/Principal at Tokyo University of Agriculture & Technology
Kazuhiro Chiba active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - | - |
Career history of Kazuhiro Chiba
Former positions of Kazuhiro Chiba
| Companies | Position | Start | End |
|---|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Director/Board Member | 07/04/2005 | - |
| Chief Tech/Sci/R&D Officer | 07/04/2005 | - | |
| Founder | 07/04/2005 | - |
Training of Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Statistics
International
| Japan | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Private companies | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Kazuhiro Chiba
- Experience
